Tuesday, October 13, 2020 11:47:50 AM
Speculative post here, also shared on Twitter lol, but Tiggeriffic shared something interesting that maybe deserves to be looked at again in consideration with the Inhaled version of RLF ....
Could Nephron’s “Atomizer” perhaps be the method of delivery here for “long-haulers” with symptoms if efficacy is shown there? Curiously named “E-100”..... Not saying it’s by any means ready to go but just doing some dot connecting here, since Nephron is supposed to be rolling out the inhaled version as per PR linked below??
https://www.nephronpharm.com/products/ez-breathe-atomizer
“The development partners, NeuroRx and Relief, are leading US and EU commercialization plans, respectively. They have now contracted with Nephron Pharmaceuticals, Inc. to manufacture commercial supplies of RLF-100™, in order to ensure that adequate drug inventory will be immediately available, should the clinical trials demonstrate safety and efficacy.”
Taken from Sept. 30 PR:
https://www.prnewswire.com/news-releases/neurorx-and-relief-therapeutics-establish-supply-and-distribution-agreements-for-rlf-100-aviptadil-301140389.html
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM